checkAd
    Regeneron Pharmaceuticals Aktie
    903,48
     
    USD
    +1,44 %
    +12,82 USD
    Letzter Kurs 02:00:00 Nasdaq
    903,02
     
    USD
    600 STK
    Geldkurs 01.05.24
    903,31
     
    USD
    200 STK
    Briefkurs 01.05.24
    ISIN: US75886F1075 · WKN: 881535 · SYM: RQP · USA

    Neueste Nachrichten

    EYLEA HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
    29.04.24 · globenewswire · Regeneron Pharmaceuticals
    Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
    25.04.24 · globenewswire · Regeneron Pharmaceuticals
    Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
    24.04.24 · globenewswire · Regeneron Pharmaceuticals
    Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
    22.04.24 · globenewswire · Regeneron Pharmaceuticals
    The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
    17.04.24 · Business Wire (engl.) · Regeneron Pharmaceuticals
    Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
    07.04.24 · globenewswire · Regeneron Pharmaceuticals
    Regeneron to Report First Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on May 2, 2024
    01.04.24 · globenewswire · Regeneron Pharmaceuticals
    Regeneron Provides Update on Biologics License Application for Odronextamab
    25.03.24 · globenewswire · Regeneron Pharmaceuticals
    High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
    13.03.24 · globenewswire · Regeneron Pharmaceuticals
    Praluent (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
    11.03.24 · globenewswire · Regeneron Pharmaceuticals
    EYLEA HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The Lancet
    08.03.24 · globenewswire · Regeneron Pharmaceuticals
    Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
    23.02.24 · globenewswire · Regeneron Pharmaceuticals